As technology advances, it raises a crucial question: Are our societal structures poised to embrace the insights AI brings to dementia treatment- and care?

Dementia is one of our most pressing global health challenges, with over 55 million people already living with this condition globally. Estimates by Alzheimer's Disease International suggest that this number might rise to as many as 80 million by 2030.
The impact of the disease on the individual is vast and profound, affecting not only the sufferer but also their families and the wider community. There's an urgent need for more accurate diagnostic tools than we currently have to detect the early development of the disease so that effective treatments can be started before brain damage worsens.
While we know several factors that increase the risk of dementia, we currently lack both tools for early detection and effective treatments. Innovations like AI technology shine hope at this critical juncture of limited knowledge and resources.
Mild Cognitive Impairment (MCI): A Vulnerable Transitional Phase
As the brain ages, our cognitive vulnerability increases, challenging older people's ability to maintain their independence. MCI is an intermediate stage - somewhere between normal brain ageing and dementia - where individuals face an increased risk of developing dementia later on.
This condition requires swift risk assessment, but the lack of precise diagnostic tools prolongs patient evaluations. Efforts often commence only after dementia has set in.
The Quest for a Cure
Almost a decade ago, I had the pleasure of working at The Norwegian Health Association, advocating for people with dementia and their families and racing resources for research.
My task was to disseminate research from the organisation's dementia research program. This program was funded by donations collected during the Norwegian Broadcasting Corporation (NRK) 2013 Fundraising Campaign, with the funds being allocated to various Norwegian research projects. Through translational research, the goal was to gain as much knowledge about the disease as possible to find a cure.
As I explored themes like brain health, genetics, epigenetics and lifestyle interventions, one question became clear: Could technology answer this unresolved public health issue before medicine does? In a fanciful thought, perhaps inspired mainly by robotics and a bit of sci-fi, I imagined a future where we create digital replicas of ourselves, acting as “pacemakers for the brain" that can be activated in cases of cognitive decline.
New Perspectives After Disappointing Medication Trials
To much disappointment, several significant medication trials for a cure against dementia famously failed during this period. This adversity led to reevaluating previous assumptions about the disease's causes. Although the leading theory that tau protein and beta-amyloid caused harmful plaque in the brain was still being investigated, researchers began exploring other potential factors.
From Live Data to Disease Prognosis
Despite the extensive effort and substantial resources invested, the path to more precise and effective diagnostics has been bumpy. However, the seemingly slow progress in dementia research has paved the way for groundbreaking technological approaches. This shift in the research landscape became especially evident during Arendalsuka 2023, an annual event held in Arendal, Norway, that brings together politicians, organisations, businesses, and the public to discuss and debate critical national topics. It is an open arena for political discussions, workshops, and networking, with participation from a wide range of Norwegian stakeholders.
During Arendal Week 2023, neurologist and psychiatrist Ira Haraldsen presented the AI-Mind research initiative. Coordinated by the Cognitive Health Research Group at Oslo University Hospital, the initiative aims to revolutionise dementia diagnostics using AI-driven tools. Haraldsen heads the effort, initially involving 1,000 participants from Norway, Finland, Italy, and Spain.
Through my previous work on the Lighthouse Project DoMore! (2016-2021) At OUS, where AI was used to diagnose and predict historical cancer samples, I quickly recognised similarities and differences in the approaches. In DoMore!, machines were trained on scans from previous cancer samples where patient outcomes were already known. This contrasts with AI-Mind, which collects data from living individuals and monitors their health over time to see if they eventually develop dementia.
The Need for a National Effort
To develop practical AI algorithms for detecting MCI, Haraldsen emphasised the need for comprehensive data collection. She compared the situation to the fight against AIDS to underscore the importance of a coordinated national initiative.
In her presentation, Haraldsen highlighted the progress in AIDS research as a shining example of what collective efforts can achieve. She argued that, like AIDS, early diagnosis is the key to developing effective treatments for cognitive impairment and dementia.
Comprehensive data from individuals with early signs of cognitive impairment will allow AI technology to fine-tune and enhance current diagnostic methods, which are often time-consuming and lack precision. Haraldsen and AI-Mind’s objective is to establish strategies that can quickly and accurately assess an individual's risk of dementia.
A cloud-based diagnostic platform
An early diagnosis allows for interventions that can slow the progression of the disease. Lifestyle changes can be implemented, risk factors such as blood pressure, diabetes, and infections can be monitored, and patients can fully benefit from current and future medications for dementia before the disease causes irreversible brain damage. AI-Mind takes the next step by offering the following AI-driven tools to provide a more detailed and accurate diagnosis:
AI-Mind Connector: EEG data will identify disturbances in brain circuitry, which could be early signs of cognitive changes that might develop into dementia.
AI-Mind Predictor: This tool will combine data from the Connector with cognitive tests and blood analyses to provide a highly accurate assessment of a patient's dementia risk.
The tools will be available to medical professionals via a cloud-based diagnostic platform. By using these tools, AI-Mind researchers hope to accelerate the diagnosis process. This can ensure that patients receive appropriate treatment earlier, potentially slowing the disease's progression or preventing its onset.
Early prognosis, then what? Technological breakthroughs, especially in AI, pave the way for revolutionary changes in dementia diagnostics. Yet, there are aspects of today's dementia care that should be considered before going all-in on artificial intelligence.
The World Alzheimer Report 2022 reveals that many individuals with dementia currently feel left to their own devices post-diagnosis. The data indicates that 45% in low-income countries and 37% in high-income countries did not receive adequate support post-diagnosis. Alarmingly, 62% of informal caregivers in low-income countries and 36% in high-income countries reported a lack of support for those they care for.
The report demonstrates that efforts to enhance post-diagnosis support need to intensify to ensure effectiveness, equity, and accessibility. Given the challenges in geriatrics and elder care in our country, we must ask: Is it truly beneficial for people with mild cognitive impairment (MCI) to get an early diagnosis if we still don't have access to effective treatments?
Like any groundbreaking technological insight, the real challenges often don't lie solely in the technology itself but in our ability to integrate it in a manner that genuinely benefits the patients. The World Alzheimer Report 2022 paints a bleak picture of the lack of support for dementia sufferers post-diagnosis. Ironically, an early diagnosis may place patients in a medical void. Even if we can identify the issue earlier, the treatment and support opportunities might not be equipped to handle this new influx of diagnosed patients.
While technology races ahead, there's little indication that the world’s health and care systems can keep pace. The true power of AI diagnostics will only be realised when comprehensive and compassionate treatment strategies complement it. The commitment Ira Haraldsen and AI-Mind call for must be a monumental effort, ensuring AI diagnostics doesn't become an empty promise.
Technological advancement requires a systemic response. The next wave of innovation in dementia care should be technological and systemic. We must look beyond algorithms and deep learning and ask ourselves: Are we, as a society, genuinely prepared for the insights AI provides? When will our health and care systems be bolstered to support the new generation of early-diagnosed dementia patients in a meaningful and dignified manner?
About me
I am Kari Andresen, behind the newsletter The Creative Nexus. As a communications professional with over 20 years of experience and a degree in the history of ideas, I specialise in technology, science, and health. From 2016-2021, I led the outreach for the Norwegian R&D flagship project DoMore! on AI-based cancer diagnostics.
Use of AI
This newsletter was created with assistance from OpenAI's ChatGPT and has been carefully edited and quality-checked by me, the author, to ensure accuracy and relevance. The visualisations were generated with the AI tool Midjourney, but the final design results from my choices. Although AI tools have been beneficial, my human judgment and professional expertise guide the final content.

